These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 18083035
1. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships. Caterina MC, Perillo IA, Boiani L, Pezaroglo H, Cerecetto H, González M, Salerno A. Bioorg Med Chem; 2008 Mar 01; 16(5):2226-34. PubMed ID: 18083035 [Abstract] [Full Text] [Related]
2. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships. Porcal W, Hernández P, Aguirre G, Boiani L, Boiani M, Merlino A, Ferreira A, Maio RD, Castro A, González M, Cerecetto H. Bioorg Med Chem; 2007 Apr 01; 15(7):2768-81. PubMed ID: 17287123 [Abstract] [Full Text] [Related]
3. New imidazolidine derivatives as anti-Trypanosoma cruzi agents: structure-activity relationships. Dos Santos Gomes FO, de Melo CM, Peixoto CA, de Lima Mdo C, Galdino SL, Pereira VR, da Rocha Pitta I. Parasitol Res; 2012 Dec 01; 111(6):2361-6. PubMed ID: 22941528 [Abstract] [Full Text] [Related]
5. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships. Bollini M, Casal JJ, Alvarez DE, Boiani L, González M, Cerecetto H, Bruno AM. Bioorg Med Chem; 2009 Feb 15; 17(4):1437-44. PubMed ID: 19168363 [Abstract] [Full Text] [Related]
6. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi. da Silva EN, Menna-Barreto RF, Pinto Mdo C, Silva RS, Teixeira DV, de Souza MC, De Simone CA, De Castro SL, Ferreira VF, Pinto AV. Eur J Med Chem; 2008 Aug 15; 43(8):1774-80. PubMed ID: 18045742 [Abstract] [Full Text] [Related]
9. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies. Boiani L, Aguirre G, González M, Cerecetto H, Chidichimo A, Cazzulo JJ, Bertinaria M, Guglielmo S. Bioorg Med Chem; 2008 Sep 01; 16(17):7900-7. PubMed ID: 18706821 [Abstract] [Full Text] [Related]
11. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents. Paula FR, Jorge SD, de Almeida LV, Pasqualoto KF, Tavares LC. Bioorg Med Chem; 2009 Apr 01; 17(7):2673-9. PubMed ID: 19303308 [Abstract] [Full Text] [Related]